No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MNKD250117C5500
- 0.65
- +0.05+8.33%
15min DelayTrading Jan 15 10:21 ET
0.68High0.05Low
0.68Open0.60Pre Close39 Volume2.97K Open Interest5.50Strike Price2.12KTurnover113.80%IV0.08%PremiumJan 17, 2025Expiry Date0.65Intrinsic Value100Multiplier2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.8943Delta0.3361Gamma9.45Leverage Ratio-0.0208Theta0.0003Rho8.45Eff Leverage0.0009Vega
Intraday
- 5D
- Daily
News
MannKind Announces Upcoming Retirement of Lauren Sabella
Press Release: MannKind Expands Executive Leadership Team
Here's Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10
MannKind Expands Executive Leadership Team
MannKind Shares Rise After Wells Fargo Begins Coverage
Leerink Partners Maintains MannKind(MNKD.US) With Buy Rating, Announces Target Price $9